newsFDA Fast Track designation for photodynamic cancer therapy28 November 2022 | By Catherine Eckford (European Pharmaceutical Review)REM-001, a photodynamic therapy for cutaneous metastatic breast cancer has been given Fast Track designation by the US Food and Drug Administration (FDA).